Floatz logo

Tenofovir Disoproxil Fumarate

Chronic Hepatitis B Virus Infection

Ningbo No.2 HospitalSmall moleculePhase 4 / ApprovedActive
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
60/ 100
Competitive Position
89/ 100

Competitive context

10 Active assets in the Chronic Hepatitis B Virus Infection cohort.

Asset / SponsorPhaseRating
Lamivudine
Yonsei University
Phase 4BBB
Entecavir
Beijing Continent Pharmaceutical Co, Ltd.
Phase 4BBB
Telbivudine
The Fifth People's Hospital of Suzhou
Phase 4BBB
PEGYINTERFERON-ALFA-2A
Huashan Hospital
Phase 4BB
Tenofovir Alafenamide
Ningbo No.2 Hospital
Phase 4BB

View all 25 →

Same molecule, other indications

Tenofovir Disoproxil Fumarate is also rated in:

HIV infectious diseaseActive
BBB
Indicative · Phase 4
72 / 100
View asset →
lipodystrophyDormant
BB
Indicative · Phase 4
69 / 100
View asset →
mixed anxiety and depressive disorderDormant
BB
Indicative · Phase 4
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →